(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 7.72% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.77%.
Gevo's revenue in 2026 is $174,419,000.On average, 8 Wall Street analysts forecast GEVO's revenue for 2026 to be $46,971,084,157, with the lowest GEVO revenue forecast at $40,708,110,662, and the highest GEVO revenue forecast at $55,317,658,629. On average, 8 Wall Street analysts forecast GEVO's revenue for 2027 to be $51,552,085,369, with the lowest GEVO revenue forecast at $43,843,248,579, and the highest GEVO revenue forecast at $58,477,137,679.
In 2028, GEVO is forecast to generate $52,365,079,208 in revenue, with the lowest revenue forecast at $44,337,373,577 and the highest revenue forecast at $60,088,520,677.